Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.

Simple item page
dc.contributor.authorKuscu N.K.
dc.contributor.authorKoyuncu F.M.
dc.date.accessioned2024-07-22T08:25:12Z
dc.date.available2024-07-22T08:25:12Z
dc.date.issued2002
dc.description.abstractInsulin plays a major role in polycystic ovary syndrome (PCOS). Insulin resistance and resultant hyperinsulinemia stimulate both the ovary and adrenal to produce androgens. Oral antidiabetic agents have been used to alleviate the symptoms and to induce ovulation in women with PCOS. This review focuses on the relation between insulin and PCOS and discusses the use of oral antidiabetic agents.
dc.identifier.issn15212076
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20313
dc.language.isoEnglish
dc.subjectAdministration, Oral
dc.subjectChromans
dc.subjectFemale
dc.subjectHumans
dc.subjectHypoglycemic Agents
dc.subjectInsulin
dc.subjectMetformin
dc.subjectOvulation
dc.subjectPolycystic Ovary Syndrome
dc.subjectThiazoles
dc.subjectThiazolidinediones
dc.subject2,4 thiazolidinedione derivative
dc.subjectantidiabetic agent
dc.subjectchroman derivative
dc.subjectinsulin
dc.subjectmetformin
dc.subjectthiazole derivative
dc.subjecttroglitazone
dc.subjectdrug effect
dc.subjectfemale
dc.subjecthuman
dc.subjectoral drug administration
dc.subjectovary polycystic disease
dc.subjectovulation
dc.subjectpathophysiology
dc.subjectreview
dc.titleInsulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
dc.typeReview

Files

Collections

Scopus Koleksiyonu